{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:27:26Z","timestamp":1790940446607,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":4151,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jpainsymman.2007.10.005","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T09:21:22Z","timestamp":1208251282000},"page":"289-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Intravenous Ibandronate Rapidly Reduces Pain, Neurochemical Indices of Central Sensitization, Tumor Burden, and Skeletal Destruction in a Mouse Model of Bone Cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"Kyle G.","family":"Halvorson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly A.","family":"Sevcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Ghilardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan J.","family":"Koewler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frieder","family":"Bauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick\u00a0W.","family":"Mantyh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2007.10.005_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0305-7372(98)90005-6","article-title":"Breakthrough pain in cancer patients: pathophysiology and treatment","volume":"24","author":"Mercadante","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3959(90)90004-W","article-title":"Breakthrough pain: definition, prevalence and characteristics","volume":"41","author":"Portenoy","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(96)03267-8","article-title":"Malignant bone pain: pathophysiology and treatment","volume":"69","author":"Mercadante","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib4","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","article-title":"Management of cancer pain","volume":"353","author":"Portenoy","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib5","first-page":"25","article-title":"Managing cancer pain poorly responsive to systemic opioid therapy","volume":"13","author":"Portenoy","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib6","first-page":"408","article-title":"Bisphosphonates for malignancy-related bone disease: current status, future developments","volume":"14","author":"Body","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/8756-3282(96)00182-2","article-title":"Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones","volume":"19","author":"Masarachia","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00198-004-1612-7","article-title":"Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing","volume":"15","author":"Bauss","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib9","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib10","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib11","first-page":"235","article-title":"Bisphosphonate action: aledronate localization in rat bone and effects on osteoclast ultrastructure","volume":"16","author":"Sato","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminoncol.2004.07.026","article-title":"Ibandronate in metastatic bone pain","volume":"31","author":"Heidenreich","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib13","first-page":"7343","article-title":"Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2","volume":"62","author":"Sabino","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/74999","article-title":"Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord","volume":"6","author":"Honore","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2004.06.015","article-title":"Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis","volume":"111","author":"Sevcik","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pain.2005.02.022","article-title":"Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization","volume":"115","author":"Sevcik","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib17","first-page":"4038","article-title":"Osteoprotegerin diminishes advanced bone cancer pain","volume":"61","author":"Luger","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib18","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jbmr.5650060915","article-title":"BM 21.0955, a potent new bisphosphonate to inhibit bone resorption","volume":"6","author":"Muhlbauer","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/0091270004267594","article-title":"Ibandronate: a clinical pharmacological and pharmacokinetic update","volume":"44","author":"Barrett","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib20","first-page":"2200","article-title":"Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats","volume":"29","author":"Bauss","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib21","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1359\/jbmr.1999.14.10.1768","article-title":"Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties","volume":"14","author":"Monier-Faugere","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S8756-3282(02)00923-7","article-title":"Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys","volume":"32","author":"Smith","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bone.2006.10.019","article-title":"Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs","volume":"40","author":"Gluer","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0304-3959(02)00102-1","article-title":"Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain","volume":"99","author":"Luger","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ijc.10999","article-title":"Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system","volume":"104","author":"Sabino","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0773.1996.tb00239.x","article-title":"Disposition and analgesic effects of systemic morphine, morphine-6-glucuronide and normorphine in rat","volume":"79","author":"Hasselstrom","year":"1996","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0306-4522(00)00110-X","article-title":"Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons","volume":"98","author":"Honore","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib28","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1212\/WNL.45.10.1848","article-title":"Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy","volume":"45","author":"McCarty","year":"1995","journal-title":"neurology"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/328632a0","article-title":"Induction of c-fos-like protein in spinal cord neurons following sensory stimulation","volume":"328","author":"Hunt","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib30","first-page":"19","article-title":"Tumor-bone interactions in skeletal metastasis","author":"Orr","year":"1995","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib31","first-page":"27","article-title":"Phenotype and functions of intratumoral macrophages","volume":"865","author":"McBride","year":"1986","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s004410050017","article-title":"Retrograde tracing and neuropeptide immunohistochemistry of sensory neurones projecting to the cartilaginous distal femoral epiphysis of young rats","volume":"299","author":"Edoff","year":"2000","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/cne.902600208","article-title":"Spinal cord projections from hindlimb muscle nerves in the rat studied by transganglionic transport of horseradish peroxidase, wheat germ agglutinin conjugated horseradish peroxidase, or horseradish peroxidase with dimethylsulfoxide","volume":"260","author":"Molander","year":"1987","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1097-0185(20001001)260:2<180::AID-AR70>3.0.CO;2-E","article-title":"Contribution of femoral and proximal sciatic nerve branches to the sensory innervation of hindlimb digits in the rat","volume":"260","author":"Puigdellivol-Sanchez","year":"2000","journal-title":"Anat Rec"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(98)00518-7","article-title":"Sciatic and femoral nerve sensory neurones occupy different regions of the L4 dorsal root ganglion in the adult rat","volume":"251","author":"Puigdellivol-Sanchez","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0079-6123(00)29030-4","article-title":"Cellular and neurochemical remodeling of the spinal cord in bone cancer pain","volume":"129","author":"Honore","year":"2000","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib37","doi-asserted-by":"crossref","first-page":"10886","DOI":"10.1523\/JNEUROSCI.19-24-10886.1999","article-title":"Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain","volume":"19","author":"Schwei","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3959(01)00311-6","article-title":"Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin","volume":"92","author":"Vanderah","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0304-3959(96)03225-3","article-title":"Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone","volume":"68","author":"Vanderah","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90078-9","article-title":"Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization","volume":"455","author":"Iadarola","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0169-328X(91)90065-6","article-title":"Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons","volume":"10","author":"Noguchi","year":"1991","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib42","series-title":"Biology and physiology of the osteoclast","first-page":"289","article-title":"Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption","author":"Delaisse","year":"1992"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(02)00165-3","article-title":"Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur","volume":"113","author":"Mach","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib44","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0896-6273(00)80564-4","article-title":"The cloned capsaicin receptor integrates multiple pain-producing stimuli","volume":"21","author":"Tominaga","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib46","doi-asserted-by":"crossref","first-page":"28819","DOI":"10.1074\/jbc.272.46.28819","article-title":"The acid-sensitive ionic channel subunit ASIC and the mammalian degenerin MDEG form a heteromultimeric H+-gated Na + channel with novel properties","volume":"272","author":"Bassilana","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib47","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00001756-199804200-00028","article-title":"An acid sensing ion channel (ASIC) localizes to small primary afferent neurons in rats","volume":"9","author":"Olson","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/386173a0","article-title":"A proton-gated cation channel involved in acid-sensing","volume":"386","author":"Waldmann","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib50","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1158\/1078-0432.CCR-05-2766","article-title":"Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo","volume":"12","author":"Wakchoure","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib51","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/nn1804","article-title":"Dynorphin A activates bradykinin receptors to maintain neuropathic pain","volume":"9","author":"Lai","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3959(00)00243-8","article-title":"Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats","volume":"86","author":"Malan","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.2000.tb06673.x","article-title":"Spinal and supraspinal mechanisms of neuropathic pain","volume":"909","author":"Ossipov","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib54","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1523\/JNEUROSCI.21-05-01779.2001","article-title":"Pronociceptive actions of dynorphin maintain chronic neuropathic pain","volume":"21","author":"Wang","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib55","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1258\/0004563011901037","article-title":"Bisphosphonates: an overview with special reference to alendronate","volume":"38","author":"Vasikaran","year":"2001","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib56","first-page":"4418","article-title":"The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases","volume":"61","author":"Hiraga","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib57","first-page":"2708","article-title":"Alendronate inhibits invasion of the PC-3 prostate cancer cells by affecting the mevalonate pathway","volume":"62","author":"Virtanen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib58","first-page":"5294","article-title":"The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway","volume":"58","author":"Shipman","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib59","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1359\/jbmr.2000.15.11.2211","article-title":"Bisphosphonates induce breast cancer cell death in vitro","volume":"15","author":"Fromigue","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1191\/0269216303pm800ra","article-title":"The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia","volume":"17","author":"Neville-Webbe","year":"2003","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0928-0987(03)00108-8","article-title":"Inhibition of the mevalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cytokine secretion from macrophages in vitro","volume":"19","author":"Toyras","year":"2003","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib62","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1359\/jbmr.1998.13.11.1721","article-title":"Human osteoclast formation and activity in vitro: effects of alendronate","volume":"13","author":"Breuil","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib63","first-page":"2949","article-title":"Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases","volume":"60","author":"Boissier","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002230010047","article-title":"Alendronate disturbs vesicular trafficking in osteoclasts","volume":"70","author":"Alakangas","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib65","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.11397","article-title":"Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth","volume":"107","author":"Neudert","year":"2003","journal-title":"Int\u00a0J Cancer"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib66","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","article-title":"Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials","volume":"88","author":"Lipton","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0304-3959(02)00040-4","article-title":"Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain","volume":"100","author":"Walker","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib68","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib69","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib70","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow","volume":"83","author":"Hughes","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpainsymman.2007.10.005_bib71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jbmr.5650050107","article-title":"Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy","volume":"5","author":"Sato","year":"1990","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392408001012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392408001012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:00:20Z","timestamp":1760130020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392408001012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0885392408001012"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.10.005","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Ibandronate Rapidly Reduces Pain, Neurochemical Indices of Central Sensitization, Tumor Burden, and Skeletal Destruction in a Mouse Model of Bone Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}